Deciphering NF-κB pathways in smoking-related lung carcinogenesis
Authors:
- Riya ThapaRTRiya Thapa
- Ehssan MogladEMEhssan Moglad
- Ahsas GoyalAGAhsas Goyal
- Asif Ahmad BhatABAsif Ahmad Bhat
- Waleed Hassan AlmalkiWAWaleed Hassan Almalki
- Imran KazmiIKImran Kazmi
- Sami I. AlzareaSASami I. Alzarea
- Haider AliHAHaider Ali
- Brian Gregory OliverBrian Gregory Oliver
- Ronan MacLoughlinRonan MacLoughlin
- Harish DurejaHDHarish Dureja
- Sachin Kumar SinghSSSachin Kumar Singh
Open Access
- 19 August 2024
- journal article
- review article
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 23, 991-1017
Abstract
One of the main causes of death worldwide is lung cancer, which is largely caused by cigarette smoking. The crucial transcription factor NF-κB, which controls inflammatory responses and various cellular processes, is a constitutively present cytoplasmic protein strictly regulated by inhibitors like IκB proteins. Upon activation by external stimuli, it undergoes phosphorylation, translocates into the nucleus, and modulates the expression of specific genes. The incontrovertible association between pulmonary malignancy and tobacco consumption underscores and highlights a public health concern. Polycyclic aromatic hydrocarbons and nitrosamines, potent carcinogenic compounds present in the aerosol emitted from combusted tobacco, elicit profound deleterious effects upon inhalation, resulting in severe perturbation of pulmonary tissue integrity. The pathogenesis of smoking-induced lung cancer encompasses an intricate process wherein NF-κB activation plays a pivotal role, triggered by exposure to cigarette smoke through diverse signaling pathways, including those associated with oxidative stress and pro-inflammatory cytokines. Unraveling the participation of NF-κB in smoking-induced lung cancer provides pivotal insights into molecular processes, wherein intricate crosstalk between NF-κB and pathways such as MAPK and PI3K-Akt amplifies the inflammatory response, fostering an environment conducive to the formation of lung cancer. This study reviews the critical function of NF-κB in the complex molecular pathways linked to the initiation and advancement of lung carcinogenesis as well as potential treatment targets.Keywords
This publication has 167 references indexed in Scilit:
- Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and agingArchives of Toxicology, 2023
- From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disordersJournal of Biochemical and Molecular Toxicology, 2023
- Gift bags from the sentinel cells of the immune system: The diverse role of dendritic cell-derived extracellular vesiclesJournal of Leukocyte Biology, 2021
- Angiotensin‐(1‐7)‐mediated Mas1 receptor/NF‐κB‐p65 signaling is involved in a cigarette smoke‐induced chronic obstructive pulmonary disease mouse modelEnvironmental Toxicology, 2017
- Celecoxib for rheumatoid arthritisCochrane Database of Systematic Reviews, 2017
- Cigarette Smoke Extract: A Preclinical Model of Tobacco DependenceCurrent Protocols in Neuroscience, 2016
- Lung Cancer in Never Smokers2015
- Impact of smoking on inflammation: overview of molecular mechanismsInflammation Research, 2011
- Macrophages and NF-κB in Cancer2010
- Cigarette smoke condensate induces nuclear factor kappa‐b activity and proangiogenic growth factors in aerodigestive cellsThe Laryngoscope, 2010